{
    "clinical_study": {
        "@rank": "92499", 
        "acronym": "Becker-HS", 
        "arm_group": {
            "arm_group_label": "Dystrophinopathy", 
            "description": "Patients with mutations in the DMD gene and Becker muscular dystrophy and/or dilated cardiomyopathy"
        }, 
        "biospec_descr": {
            "textblock": "Whole blood, serum"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether electrocardiogram, echocardiography,\n      cardiac MRI, sera biomarkers can improve early detection of myocardial involvement and\n      clinical outcome."
        }, 
        "brief_title": "Prospective Becker-Heart-Study", 
        "completion_date": {
            "#text": "June 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Dilated Cardiomyopathy", 
            "Lef Ventricular Dysfunction", 
            "Heart Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiomyopathy, Dilated", 
                "Muscular Dystrophy, Duchenne", 
                "Heart Failure", 
                "Muscular Dystrophies", 
                "Ventricular Dysfunction", 
                "Cardiomyopathies"
            ]
        }, 
        "detailed_description": {
            "textblock": "A cohort of 100 patients with mutations in the dystrophin gene associated with Becker\n      muscular dystrophy and/or dilated cardiomyopathy will be included (patients with Duchenne\n      muscular dystrophy are excluded).\n\n      Patients with undergo at baseline the following workups: electrocardiogram,\n      echocardiography, cardiac MRI, sera biomarkers measurement.\n\n      At 3 years and 5 years, patients will be investigated according to the same protocol and\n      occurrence of cardiac adverse events in the meanwhile will be recorded.\n\n      Statistical analysis will assess correlations between cardiac phenotype and DMD mutations\n      and prognostic value of cardiac investigations."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  mutation in the DMD gene\n\n          -  Becker muscular dystrophy and/or dilated cardiomyopathy\n\n          -  age>18 years\n\n          -  affiliation to the French medical insurance\n\n        Exclusion Criteria:\n\n          -  Duchenne muscular dystrophy\n\n          -  Any other chronic disease that may be associated with heart disease"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with mutations in the DMD gene and Becker muscular dystrophy and/or dilated\n        cardiomyopathy"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020954", 
            "org_study_id": "Becker-Heart-Study"
        }, 
        "intervention": {
            "arm_group_label": "Dystrophinopathy", 
            "intervention_name": "ECG, echocardiography, cardiac MRI, sera biomarkers", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2013", 
        "location": {
            "contact": {
                "email": "n.benammar@institut-myologie.org", 
                "last_name": "Nawal Berber, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "state": "Ile de France", 
                    "zip": "75013"
                }, 
                "name": "Institut de Myologie"
            }, 
            "investigator": {
                "last_name": "Karim Wahbi, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Cohort Study of Patients With Mutations in the Dystrophin Gene (X Linked Dilated Cardiomyopathy and Becker Muscular Dystrophy)", 
        "overall_contact": {
            "email": "karim.wahbi@cch.aphp.fr", 
            "last_name": "Karim Wahbi, MD, PhD"
        }, 
        "overall_official": {
            "affiliation": "Institut de Myologie, Cochin Hospital, Paris", 
            "last_name": "Karim Wahbi, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Left ventricular ejection fraction", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020954"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Institut de Myologie, France", 
            "investigator_full_name": "Karim WAHBI", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Composite endpoint: hospitalisation for heart failure, death due to heart failure", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "source": "Institut de Myologie, France", 
        "sponsors": {
            "collaborator": {
                "agency": "Institut de Myologie, France", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Karim WAHBI", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}